XT
PDSB icon

XTX Topco’s PDS Biotechnology PDSB Stock Holding History

XTX Topco’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.9K Buy
36,211
+1,993
+6% +$1.5K ﹤0.01% 3527
2025
Q4 		$26.3K Buy
34,218
+14,519
+74% +$13.1K ﹤0.01% 3000
2025
Q3 		$19.9K Buy
+19,699
New +$23.2K ﹤0.01% 2329
2025
Q1 		– Sell
-24,535
Closed -$40K – 2927
2024
Q4 		$40K Sell
24,535
-42,647
-63% -$113K ﹤0.01% 1936
2024
Q3 		$257K Buy
67,182
+47,528
+242% +$159K 0.02% 1294
2024
Q2 		$57.6K Sell
19,654
-40,600
-67% -$130K ﹤0.01% 1496
2024
Q1 		$239K Buy
+60,254
New +$310K 0.03% 1037
2022
Q3 		– Sell
-21,085
Closed -$77K – 1316
2022
Q2 		$77K Buy
+21,085
New +$100K 0.03% 698

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

XTX Topco's PDSB Position: Q1 2026 in Review

XTX Topco increased its PDS Biotechnology (PDSB) stake by 5.8% in Q1 2026, buying an estimated $1.5K and bringing the position to 36,211 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3527.

XTX Topco first reported a position in PDSB in Q2 2022 and has held it in 8 quarters since. The position peaked at $257K in Q3 2024. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • XTX Topco held 36,211 shares of PDS Biotechnology worth $21.9K as of Q1 2026.
  • XTX Topco bought 1,993 PDS Biotechnology shares in Q1 2026, an estimated $1.5K.
  • PDS Biotechnology made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3527 holding.
  • XTX Topco first reported a position in PDS Biotechnology in Q2 2022 and has held it in 8 quarters since.
  • XTX Topco's PDS Biotechnology position peaked at $257K in Q3 2024.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.